GRK2 plays a key role in the regulation of a variety of these receptors and cardiac muscle expression is altered in pathological situations at the promoter level such as in CHF [36], portal hypertension [37], and other tissues and cells, such as lymphocytes [38] in these conditions. The gene discussed is GRK2; the disease is portal hypertension.